<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01341210</url>
  </required_header>
  <id_info>
    <org_study_id>201101071RC</org_study_id>
    <nct_id>NCT01341210</nct_id>
  </id_info>
  <brief_title>Observational Study of the Decision Making Towards Clinical Trials in Cancer Patients</brief_title>
  <official_title>The Study of the Knowledge, Attitudes, and Decision Making Towards Clinical Trials in Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a cross-sectional, observational and correlational survey study.This study is aim to&#xD;
      survey the the knowledge, attitudes, and decision making towards clinical trials in cancer&#xD;
      patients in Taiwan (R.O.C.), which attempts to invite some cancer patients who have been&#xD;
      experienced the treatment clinical trials' informed consent process. The research tool is a&#xD;
      questionnaire which includes some scale: (1)Clinical trial Knowledge scale, (2) Attitude&#xD;
      toward randomized clinical trials scale, (3) Shared Decision Making(SDM-Q-9),(4) Satisfaction&#xD;
      with Decision (SWD-scale), and (5) Decision Regret scale(DRS). The investigators expect the&#xD;
      research outcome can provide some instructions to improve patients' autonomy, satisfaction of&#xD;
      the decision making and communication process between patients and Medical professors&#xD;
      whenever cancer patients participating in clinical trials.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is been conduct in National Taiwan University Hospital , Taiwan. The main&#xD;
      measurement tool is a self-report questionnaire, which is designed to answer some outcome&#xD;
      measures for the following aspect:&#xD;
&#xD;
        1. To find out the knowledge, attitudes, shared decision making level, subjective norm, and&#xD;
           behavior intentions towards clinical trials in cancer patients.&#xD;
&#xD;
        2. To find out the main influencing factors of behavior intentions towards participating in&#xD;
           clinical trials&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The influencing factors of behavior intentions towards participating in clinical trials</measure>
    <time_frame>in 24 months</time_frame>
    <description>The influencing factors was defined as following measurement scale:&#xD;
Knowledge&#xD;
Attitude&#xD;
decision making process&#xD;
sex&#xD;
age&#xD;
education</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The knowledge towards clinical trials in cancer patients</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The attitudes towards clinical trials in cancer patients</measure>
    <time_frame>in 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The shared decision making level towards clinical trials in cancer patients</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The subjective norm and behavior intentions towards clinical trials in cancer patients</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Liver Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult, cancer patients who have experience in contact with clinical trials&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Cancer patients who have been approved lung cancer or liver cancer.&#xD;
&#xD;
          2. Patients who have been experienced the Informed consent process about clinical trial,&#xD;
             which duration is in 6 months before they enter this study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who have conscious disorientation that can not answer questionnaire&#xD;
&#xD;
          2. Patients only participate in some Gene clinical trials without treatment or drugs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wen-Yu Hu, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University, Department of Nursing</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ming-Tzu Wu, Master</last_name>
    <phone>+886-926257263</phone>
    <email>r98426005@ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wen-Yu Hu, PHD</last_name>
      <phone>+886-2-23123456</phone>
      <phone_ext>63160</phone_ext>
      <email>ntuhrec@ntuh.gov.tw</email>
    </contact>
    <investigator>
      <last_name>Wen-Yu Hu, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <study_first_submitted>April 21, 2011</study_first_submitted>
  <study_first_submitted_qc>April 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2011</study_first_posted>
  <last_update_submitted>August 23, 2013</last_update_submitted>
  <last_update_submitted_qc>August 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Taiwan University Hospital</investigator_affiliation>
    <investigator_full_name>National Taiwan University Hospital</investigator_full_name>
    <investigator_title>National Taiwan University Hospital</investigator_title>
  </responsible_party>
  <keyword>Patients Satisfaction</keyword>
  <keyword>Decision Making</keyword>
  <keyword>Informed Consent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

